Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

PositiveID develops new continuous glucose sensor

PositiveID, a developer of biological detection systems, has developed a new reproducible closed-cycle, continuous glucose sensor.

Based on Receptor’s chemistry platform, the glucose sensor is a critical component of the company’s implantable RFID glucose-sensing microchip – GlucoChip, which will measure glucose levels in individuals with diabetes.

The continuous glucose sensing system components are made of simple molecular chemistry materials and designed to interact competitively with changing physiological blood glucose levels, thus generating a reproducible, measurable response.

The company will integrate the glucose-sensing system with a micro-electromechanical system signal transduction unit and the electronics of its RFID microchip to complete the development of GlucoChip.

PositiveID chairman and CEO Scott Silverman said by overcoming the Company will begin to look for major partners to accelerate the remaining development of GlucoChip, a project that has the potential to revolutionize the way people with diabetes monitor their glucose levels.